Basic Materials / Specialty ChemicalsKOSDAQ
$14120.00
+130.00 (+0.93%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-12.5B · quality 47.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$285.5B
P/E
107.4x
↑EV/EBITDA
29.0x
↑ROE
9.4%
↑Gross Margin
22.5%
↑Debt/Equity
1.70
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+0.3%
FCF CAGR
—
FCF margin
-15.1%
FCF / Net income
-2.70x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $83.09B · net income $4.63B · FCF $-12.52B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $83.09B | $83.09B | $70.30B | $62.27B | $82.35B |
| Net Income | $4.63B | $4.63B | $-15.99B | $-6.05B | $4.16B |
| EBITDA | $12.43B | $12.43B | $-6.11B | $-1.80B | $10.48B |
| EPS | 131.50 | 131.50 | -790.50 | -299.50 | 230.00 |
| Gross Margin | 22.5% | 22.5% | 16.3% | 15.7% | 24.7% |
| Operating Margin | -2.1% | -2.1% | -11.6% | -12.6% | 6.5% |
| Net Margin | 5.6% | 5.6% | -22.7% | -9.7% | 5.1% |
| Balance Sheet | |||||
| Debt/Equity | 1.70 | 1.70 | 1.46 | 0.87 | 0.61 |
| Current Ratio | 0.78 | 0.78 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-12.52B | $-12.52B | $-15.37B | $-11.65B | $-956.4M |
| Returns | |||||
| ROE | 9.4% | 9.4% | -35.9% | -10.0% | 6.2% |
| Valuation | |||||
| P/E | 107.38 | 107.38 | — | — | 25.98 |
| EV/EBITDA | 29.02 | 29.02 | — | — | 14.18 |
| P/B | 5.81 | 5.81 | 3.18 | 1.91 | 1.60 |
| Growth & Yield | |||||
| Revenue Growth | 18.2% | 18.2% | 12.9% | -24.4% | — |
| EPS Growth | 116.6% | 116.6% | -163.9% | -230.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
112.0%
EPS terminal req.
$1252.91
Spread vs growth
4.6%
5Y implied EPS CAGR
63.1%
EPS terminal req.
$1516.03
Spread vs growth
53.6%
10Y implied EPS CAGR
33.9%
EPS terminal req.
$2441.58
Spread vs growth
82.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+23.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-790.50 → 131.50
Residual
+23.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.